New eye drop shows promise for glaucoma patients
NCT ID NCT06144918
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new eye drop called SBI-100 in 56 adults with glaucoma or high eye pressure. Participants received either a low dose, high dose, or placebo drop twice daily for 14 days. Researchers measured how well the drops lowered eye pressure and checked for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SBI-100 ophthalmic emulsion (eye drop)
What this could lead to
If successful, this could lead to a new eye drop treatment to lower pressure in the eye for people with glaucoma or ocular hypertension.
What could go wrong
This is an early Phase 2 trial with only 56 participants, so results may not apply to everyone. The treatment may not work better than placebo or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eye Research Foundation
Newport Beach, California, 92663, United States
-
Global Research Management, Inc.
Glendale, California, 91204, United States
-
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania, 16066, United States